Johnson & Johnson (NYSE: JNJ) has announced positive results from the Phase 3 ASTRO study evaluating TREMFYA® (guselkumab) ...

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

EQS-News: Benzinga / Key word (s): Science Soligenix's Leadership Aims To Drive Growth In Rare Disease Markets In 2025 And ...

However, a newer lupus drug, anifrolumab (brand name Saphnelo), has shown promising results in reducing organ damage, ...

The revised estimates, based on software modeling, also show that only 1,300 Fijians are receiving antiretroviral therapy for ...

The FDA granted breakthrough therapy status to first-line petosemtamab plus pembrolizumab for PD-L1–positive recurrent or ...

Dr. Howard Schumaker and Tina Schumaker to open Relevate Ketafusion clinic in La Crosse, offering IV ketamine therapy for ...

A Phase III trial evaluating nex-z in transthyretin amyloidosis with cardiomyopathy is underway, with plans for another ...

Both the federal government and South Carolina carry out the lethal injections using a single drug, pentobarbital, a powerful sedative that some experts warn causes extreme pain and suffering when ...

The Bruins released an update on Charlie McAvoy Wednesday, noting that the defenseman remains hospitalized due to several ...

Major depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing to treatment-resistant depression (TRD).

Total duration of antibiotic therapy in adults hospitalized with sepsis was significantly shorter among those who received PCT-guided care vs standard care.